Neurothrombectomy Devices Market size was valued at USD 761.76 million in 2024 and is set to exceed USD 1.79 billion by 2037, expanding at over 6.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of neurothrombectomy devices is estimated at USD 803.2 million.
The growth of the market can be attributed to the growing concern about the rising incidences of strokes, where neurothrombectomy devices are required when a clot occurs in one of the blood vessels that supply oxygen and nutrients to the brain, causing a condition of stroke. According to the statistics, each year, there are more than 8 million new cases of ischemic stroke. Ischemic strokes account for more than 63% of all incident strokes worldwide. Further, the growing awareness among people regarding strokes, coupled with surging incidences of acute ischemic stroke among people across the globe, is also expected to add to the market growth. Additionally, escalating development of highly advanced novel suction or aspiration devices, and aspiration catheters for stroke is another significant factor that is estimated to drive the market growth further by the end of 2033.
In addition to these, factors that are believed to fuel the growth of neurothrombectomy devices market include the rising impact of stress, modern lifestyle, and unhealthy diet habits among people that have been affecting people. Moreover, surging demand for minimally invasive procedures is another significant factor that is anticipated to push the market growth during the forecast period. Besides this, the increase in the aged population is another major factor that is boosting the growth of the market, as aged people have higher chances of getting severe strokes. For instance, strokes affect around 78% of adults aged 66 and above in the United States. In other words, it becomes a bigger issue as we get older. It is predicted that the risk of getting a stroke doubles every ten years after the age of 55. Additionally, the growing investment in the research and development of advanced devices is also predicted to present the potential for market expansion over the projected time frame.
Growth Drivers
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.8% |
|
Base Year Market Size (2024) |
USD 761.76 million |
|
Forecast Year Market Size (2037) |
USD 1.79 billion |
|
Regional Scope |
|
Product Type (Clot Retrieval Devices, Aspiration Devices, Snares)
The global neurothrombectomy devices market is segmented and analyzed for demand and supply by product type into clot retrieval devices, aspiration devices, and snares. Out of these three types of segments, the clot retrieval devices segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the increasing count of blood clot procedures, coupled with the surging ratio in acute ischemic stroke throughout the world. For instance, in the United States, acute ischemic stroke is one of the major causes of mortality and disability, affecting around 8500 000 individuals annually. Acute ischemic stroke is caused majorly as a result of unhealthy lifestyles of individuals, followed by hypertension, high cholesterol level, diabetes, and so on. Moreover, patients that have a history of transient ischemic attack (TIA) are also highly prone to get an acute ischemic stroke.
End-user (Hospitals, Emergency Clinics, Specialty Clinics, Ambulatory Surgical Centers)
The global neurothrombectomy devices market is also segmented and analyzed for demand and supply by end-user into hospitals, emergency clinics, specialty clinics, and ambulatory surgical centers. Amongst these segments, the hospitals segment is expected to garner a significant share owing to the rising number of hospitals, followed by the high preference of patients to receive medical treatment for brain diseases in hospitals as a result of the presence of skilled professionals and sufficient technical help, which is also predicted to raise the market’s growth in the coming years. Hence, it is anticipated to create numerous opportunities for the growth of the segment in the coming years. On the other hand, the ambulatory surgical centers segment is also projected to witness a massive CAGR during the forecast period, owing to the shorter waiting time duration that is offered by the ambulatory surgical centers to patients, followed by the rising demand for minimally invasive procedures throughout the world. For instance, more than 11 million minimally invasive procedures are performed worldwide each year. Such a staggering ratio of minimally invasive procedures is estimated to further increase the segment’s growth in the market.
Our in-depth analysis of the global market includes the following segments:
|
By Product Type |
|
|
By End-User |
|
North American Market Forecast
North America industry is predicted to hold largest revenue share of 36% by 2037. The growth of the market can be attributed majorly to the increasing occurrence of ischemic strokes in the region. For instance, each year, around 798,000 people in the United States suffer from a stroke. Out of these strokes, approximately 615,000 are first or new strokes. Moreover, ischemic strokes account for around 88% of all these strokes. Further, the high spending on healthcare, along with adequate reimbursement policies for the treatment of ischemic strokes, is also anticipated to contribute to the market growth in the region. In addition, an upsurge in the geriatric population, followed by escalating investment in the healthcare sector, and proliferating adoption of neurology devices are also anticipated to boost the market growth in the region during the forecast period.
Europe Market Forecast
Furthermore, the Europe neurothrombectomy devices market is also projected to display notable market growth by the end of 2037. The growth of the market can be attributed to the growing patient ratio who are suffering from acute ischemic stroke. In addition to this, the surging count of mechanical thrombectomy processes done in this region is another significant factor that is estimated to accelerate the growth of the market during the forecast period. Moreover, growing public and private investment in healthcare is another key factor that is expected to boost market growth further throughout the projected time frame in the European region.
Penumbra Inc. has received the CE Mark for its technologies, Lightning 7 and Lightning 12 which are a part of the Indigo Aspiration System, with mechanical thrombectomy technology.
AngioDynamics, Inc. announced that its AlphaVac., a mechanical thrombectomy system, has been approved by the US FDA under section 510(k).
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?